膜突蛋白抗体及其相关炎性因子与急性冠状动脉综合征

杜峰; 张伟; 毛华; 郭艳丽

doi:10.13201/j.issn.1001-1439.2021.02.004

膜突蛋白抗体及其相关炎性因子与急性冠状动脉综合征

- 1 广州中医药大学第一附属医院(广州, 510405);
- 2 贵阳市第一人民医院
基金项目:
贵州省科技厅科学技术基金项目(No:黔科合J字[2013]2015号)

贵阳市科技局科技计划项目(No:筑科合[2018]1-26号)

贵阳市高层次创新型青年卫生人才项目(No:【2017】筑卫科技合同字第008号)

贵阳市人才创新创业资助项目(No:筑人才办合同字【2014】第12号)

详细信息

通讯作者: 张伟,E-mail:13610208691@163.com

中图分类号: R541.4

收稿日期: 2020-08-01

Moesin antibody and inflammatory factors and acute coronary syndrome

- 1 The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China;
- 2 The First People's Hospital in Guiyang

More Information

Corresponding author: ZHANG Wei, E-mail: 13610208691@163.com

Received Date: 01 August 2020

摘要

摘要: 目的:探讨膜突蛋白抗体与炎性因子的相关性及其在急性冠状动脉综合征(ACS)中的作用。方法:入选经选择性冠状动脉造影(CAG)确诊为ACS患者150例,动脉粥样硬化症(AS)患者40例,对照组为同期健康体检者120例。采用酶联免疫吸附实验(ELISA)检测入选者血清中膜突蛋白抗体及相关炎性因子的阳性表达水平。结果:①膜突蛋白抗体阳性检出率ACS组为36%,AS组为25%,均高于对照组5%(P＜0.01)。炎性因子阳性表达水平ACS组和AS组均较对照组显著增高,差异有统计学意义(P＜0.01);ACS组炎性因子阳性表达水平高于AS组,差异有统计学意义(P＜0.05)。②膜突蛋白抗体与相关炎性因子无相关性(P＞0.05);③ACS未服用药物(调脂、抗血小板治疗)组膜突蛋白抗体阳性检出率较服药物组高,差异有统计学意义(P＜0.01)。结论:①膜突蛋白抗体在ACS与AS中表达较高;②膜突蛋白抗体与炎性因子表达无相关性;③膜突蛋白抗体在药物干预下可下降。
- 急性冠状动脉综合征 /
- 膜突蛋白抗体 /
- 高敏C反应蛋白 /
- 肿瘤坏死因子-α /
- 白细胞介素-6 /
- 白细胞介素-8
Abstract: Objective: To detect moesin antibody and inflammatory factors in serum of patients with acute coronary syndrome(ACS).Methods: There were 150 ACS cases in ACS group, 40 atherosclerosis(AS) cases in AS group, and 120 cases of healthy persons as control. We detected serum positive level of moesin antibody and inflammatory factors using the enzyme-linked immunosorbent assay.Results:①moesin antibody-positive expression in ACS group was 34%, was 10% in AS group, and was 5% in control group(P＜0.01). Inflammatory factors expression in ACS group or AS group were increased than control group(P＜0.01). Inflammatory factors expression in ACS group exceeded AS group(P＜0.05);②There was no relationship between moesin antibody and inflammatory factors in ACS group(P＞0.01);③ Moesin antibody expression increased significantly in ACS group without drugs(antithrombotic, anti-platelet thearpy) than the medication group(P＜0.01).Conclusion:①Moesin antibody expression is relatively high in ACS group or AS group;②Moesin antibody has no connection with inflammatory factor expression;③Drug intervention can reduce the Moesin antibody expression.
- acute coronary syndrome /
- moesin antibody /
- hs-CRP /
- TNF-α /
- IL-6 /
- IL-8

HTML全文

参考文献(11)

[1]	Schwartz GG,Steg PG,Szarek M,et al.Alirocumab and cardiovascular outcomes after acute coronary syndrome[J].N Engl J Med,2018,379(22):2097-2107.
[2]	Barge-Caballero G,Barge-Caballero E,Marzoa-Rivas R,et al.Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens:short-term and long-term efficacy and safety results[J].Transpl Int,2015,28(9):1034-1041.
[3]	毛华,杜峰,胥勇,等.Moesin抗体与动脉粥样硬化相关疾病的关系.[J]中国动脉硬化杂志.2013,21(6):549-553.
[4]	中国医师协会急诊医师分会,国家卫健委能力建设与继续教育中心急诊学专家委员会,中国医疗保健国际交流促进会急诊急救分会.急性冠脉综合征急诊快速诊治指南(2019)[J].临床急诊杂志,2019,20(4):253-262.
[5]	李梦涛,尹雷,王迁,等.膜突蛋白及其抗体对人肺微血管内皮细胞损伤机制的研究[J].中华风湿病学杂志.2010,14(4):232-235.
[6]	王亚利,唐礼江,王欢,等.有氧运动对介入术后急性冠脉综合征患者血清高敏C反应蛋白及白介素-6含量的影响[J].中华物理医学与康复杂志,2014,36(4):301-303.
[7]	Frangogiannis NG.Chemokines in ischemia and reperfusion[J].Thromb Haemost,2007,97(5):738-747.
[8]	杜峰,毛华,寿志南,等.膜突蛋白抗体和GRACE评分与急性冠状动脉综合征的相关性[J].临床心血管病杂志,2014,30(7):586-589.
[9]	艾文婷,傅莹莹,李瑞,等.急性冠状动脉综合征患者血清ⅠCTP、ⅢCTP水平与TIMI危险评分的相关性分析[J].临床急诊杂志,2017,18(6):433-436,440.
[10]	Zhou Q.Statin and cardiovascular diseases[J].Curr Pharm Des,2009,15(5):467-478.
[11]	王勇,赖红梅,戴晓燕.急性冠状动脉综合征患者介入术前后外周血炎性因子水平的变化及其与预后的相关性[J].临床急诊杂志,2017,18(1):14-17.